PeptidesWeight LossLongevitySexual Health - MenSexual Health - WomenHair RestorationAnti-ParasiticSleepHow it worksFAQAboutContactLog in
Peptide therapy · Subcutaneous injection
PrescriptionU.S. Licensed PharmacyProvider-ReviewedEvidence Explained

MOTS-C: a mitochondrial-derived peptide studied for cellular signaling

MOTS-C is a 16-amino-acid peptide encoded within mitochondrial 12S rRNA. Cell and animal research links it to folate-cycle, purine-synthesis, and AMPK signaling. Human treatment results are not yet available.

From $188 first month
$188First month, renews at $220/mo
Start Assessment
✓ U.S.-licensed providers✓ HIPAA-secure✓ Free discreet shipping✓ Ongoing care included
MOTS-C product image
Mechanism and evidence

What the research says about MOTS-C

Mechanism education without turning preclinical findings into promises.

✓

Encoded in mitochondrial RNA

MOTS-C is a 16-amino-acid mitochondrial-derived peptide encoded within mitochondrial 12S rRNA. It is not an FDA-approved medication.

✓

Metabolic-pathway research

Cell and animal research links MOTS-C to inhibition of the folate cycle and de-novo purine synthesis, along with AMPK activation. Skeletal muscle is a research focus, but animal metabolic findings do not establish human benefits.

✓

Human trial results are pending

FDA identified no clinical studies or human exposure data during its review. A phase 2a trial is now recruiting, but no results have been posted. Weight-loss, insulin-sensitivity, longevity, and performance claims are unproven.

✓

A provider-directed protocol

A licensed provider reviews your history and medications before determining whether this compounded injectable option is appropriate and how it should be used.

About this treatment

Provider-reviewed care, built around the evidence

✓

Provider oversight

Prescribed only when a licensed provider determines it is appropriate based on your history, medications, and treatment goals.

✓

No mystery vials

When prescribed, your medication is prepared by and shipped directly from a licensed U.S. pharmacy in discreet packaging.

✓

Clear ingredient education

Each product page separates mechanism research from human evidence so the unknowns stay visible.

✓

Ongoing care included

Message your care team with questions about your protocol, refills, or side effects.

How it works

Care without the waiting room

Get started in 4 simple steps. No office visits required.

01

Start your assessment

A 5-minute online health questionnaire, no appointment, no waiting room.

02

Provider review

A licensed provider in your state reviews your history and prescribes if appropriate.

03

Pharmacy ships direct

When prescribed, your medication ships from a licensed U.S. pharmacy in discreet packaging.

04

Ongoing support

Message your care team anytime. Dose questions and refills are handled online.

FAQ

Questions about MOTS-C

What does the research actually show?

Published human safety and efficacy results are not available. Recruiting research is not evidence of benefit, and endogenous MOTS-C measurements are not treatment trials.

Is this medication FDA-approved?

No. This compounded medication is not FDA-approved. Compounded drugs are prepared for individual patients, and FDA does not verify their safety, effectiveness, or quality before marketing.

How do I know whether it is appropriate for me?

Complete the online assessment. A licensed provider reviews your medical history, medications, and goals before deciding whether to prescribe.

Where will I see pricing and protocol details?

Current pricing is shown on this page when a customer offer exists. Your provider-directed protocol and any additional details are confirmed during assessment and review.

Important safety informationMOTS-C is available by prescription only after evaluation by a licensed provider. This compounded medication is not FDA-approved; the FDA does not verify the safety, effectiveness, or quality of compounded drugs. Common side effects and long-term risks have not been established because published human safety results are unavailable. Injection-site and allergic reactions are possible. FDA has raised immunogenicity, aggregation, peptide-related impurity, API-characterization, and unknown-toxicology concerns. Tell your provider about all medical conditions and medications. MOTS-C is prohibited at all times under WADA S4.4.1. Individual results vary. This page is educational and is not medical advice.

Start with a provider review

Your assessment takes about 5 minutes. A licensed provider reviews your information and determines whether treatment is appropriate.

Start Assessment
Peptide therapy

Related treatments

BPC-157 product image

BPC-157

Subcutaneous injection

15 amino acids. One injectable protocol.

From $188 first month
TB-500 product image

TB-500

Subcutaneous injection

Thymosin beta-4 fragment. Injectable protocol.

From $199 first month
Coming soonKPV product image

KPV

Provider-reviewed peptide protocol

Three amino acids. One alpha-MSH fragment.

Coming soon
MOTS-CFrom $188 first month
Start Assessment